Potential Risks and Side Effects GLP-1 medications work by slowing digestion, regulating blood sugar, and suppressing appetite
Bone density testing should be individualized based on your risk factors
Use of sodium-glucose co-transporter 2 inhibitors and glucagon-like peptide-1 receptor agonists according to the 2019 ESC guidelines and the 2019 ADA/EASD consensus report in a national population of patients with type 2 diabetes
Compounded GLP-1 medications referenced in this article are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality before marketing
For about 10% of Medicare beneficiaries, GLP-1 coverage may include obesity, not just Type 2 diabetes
However, one of the most common side effects people report is tirzepatide nausea